Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats

about

Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats

Item

http://www.wikidata.org/entity/Q58773071

description

scientific article published on 16 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Enhancement of Adiponectin Ame ...... FoxO1 in Type I Diabetic Rats

@en

Enhancement of Adiponectin Ame ...... FoxO1 in Type I Diabetic Rats

@nl

type

Item

label

Enhancement of Adiponectin Ame ...... FoxO1 in Type I Diabetic Rats

@en

Enhancement of Adiponectin Ame ...... FoxO1 in Type I Diabetic Rats

@nl

prefLabel

Enhancement of Adiponectin Ame ...... FoxO1 in Type I Diabetic Rats

@en

Enhancement of Adiponectin Ame ...... FoxO1 in Type I Diabetic Rats

@nl

P1476

Enhancement of Adiponectin Ame ...... FoxO1 in Type I Diabetic Rats

@en

P2093

Dan Yan

http://www.w3.org/2001/XMLSchema#string

Jun Li

http://www.w3.org/2001/XMLSchema#string

Qiqi Zhu

http://www.w3.org/2001/XMLSchema#string

Xiang Xie

http://www.w3.org/2001/XMLSchema#string

Yong-Ping Fang

http://www.w3.org/2001/XMLSchema#string

P2860

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue

Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.

Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.

Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice

P304

6254340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/6254340

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30186875

http://www.w3.org/2001/XMLSchema#string

P921

endocrinology

P932

6116459

http://www.w3.org/2001/XMLSchema#string